Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1312-2021Class II

Coronavirus antigen detection test system -

LumiraDx / initiated 2021-02-03 / Terminated / root cause: manufacturing process

LumiraDx began a recall of Coronavirus antigen detection test system - Product Usage: intended for the qualitative detection of the nucleocapsid protein antigen to SARS-CoV-2 directly... on . FDA classified it as Class II and gives the reason as "Two lots of test strips failed QC testing using blank buffer due to false positives". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1312-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
LumiraDx
Product
Coronavirus antigen detection test system - Product Usage: intended for the qualitative detection of the nucleocapsid protein antigen to SARS-CoV-2 directly from nasal swab samples collected from individuals suspected of COVID-19 by their healthcare provider within the first twelve days of symptom onset.
Product code
QKP Coronavirus Antigen Detection Test System.
Reason for recall
Two lots of test strips failed QC testing using blank buffer due to false positives.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
On 2/23/2020, LumiraDx issued an Urgent Device Medical Corrective Field Action notice to customers, advising them of a mandatory field corrective action in the form of a software update for the LumiraDx SARS-CoV-2 Antigen (Ag) Test.
Quantity in commerce
2186 devices
Distribution
US nationwide distribution.
Product codes and lots
catalog #: L001000330001

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1312-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1312-2021Class IITerminatedVoluntary: Firm initiated